OTTAWA – Pfizer Canada says it is preparing to ask Health Canada to authorize its COVID-19 vaccine for children under the age of five by mid-October.
The US drugmaker submitted a formal request to the US Food and Drug Administration today and the FDA intends to meet on October 26 to discuss the submission.
Last week Pfizer submitted data from clinical trials on children aged five to 11 to both governments, but did not formally request authorization.
- Newsletter sign-up: Get the COVID-19 brief sent to your inbox
A spokesperson for the company’s Canadian branch says it is in the final stages of working with Health Canada before submissions are made so children between the ages of five and 11 can be given the shot.
The vaccine was authorized in December 2020 for people who are at least 16 years old and in May for adolescents 12 to 15 years old.
The dosage for young children is one-third the size given to adults and Pfizer and Health Canada have not yet said whether the vaccine supplies already in Canada’s freezers can be adapted for use on children or if New shipments must be made.
This report by The Canadian Press was first published on October 7, 2021.